Search results
Ex-N.S.A. Employee Who Tried to Sell U.S. Secrets to Russia Gets 22 Years
New York Times· 14 hours agoA former employee of the National Security Agency who thought that he was selling top secrets to the...
Sheriff’s reports from March 22-29 - Shelby County Reporter
The Shelby County Reporter· 14 hours agoSheriff’s reports from March 22-29
Decoding Pinterest Inc (PINS): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 4 hours agoAdditionally, the company must navigate an evolving regulatory environment concerning data privacy...
How Chelsea used 'Fifa reel' ploy to persuade Bellingham to sign for them
The US Sun· 19 hours agoCHELSEA used a unique approach to try and persuade a teenage Jude Bellingham to join the club. A...
LeBron James undecided on Lakers future, return for 22nd NBA season
UPI· 19 hours ago1 of 5 | Los Angeles Lakers forward LeBron James (L) averaged 25.7 points per game this season....
Hands-on aerospace lessons returning to Prairie Elementary School with Civil Air Patrol
The Daily Telegram via Yahoo News· 1 hour agoClassroom teachers, meanwhile, receive guides that are grade-level specific with 22 lessons per...
See all homes sold in Lakewood, April 22 to April 28
The Cleveland Plain Dealer· 17 hours agoThe following is a listing of all home transfers in Lakewood reported from April 22 to April 28. There were 10 transactions posted during this time....
Bee-lieve it or not: Dodgers lose another extra-inning game
True Blue LA· 3 hours agoAfter a delay of one hour, 55 minutes because of bees, the Dodgers and Diamondbacks needed extra...
See all homes sold in Westlake, April 22 to April 28
The Cleveland Plain Dealer· 17 hours agoThe following is a listing of all home transfers in Westlake reported from April 22 to April 28. There were 7 transactions posted during this time....
Harmony Biosciences Holdings Inc (HRMY) Q1 2024 Earnings Call Transcript Highlights: Strong ...
GuruFocus.com via Yahoo Finance· 11 minutes agoDiscover key financial outcomes and strategic insights from Harmony Biosciences' Q1 2024 earnings call, including robust revenue growth and promising clinical advancements.